Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexander, C. M.
Right arrow Articles by Haffner, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexander, C. M.
Right arrow Articles by Haffner, S. M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:1210-1214, 2003
© 2003 by the American Diabetes Association, Inc.

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

Charles M. Alexander1, Pamela B. Landsman1, Steven M. Teutsch1, and Steven M. Haffner2

1 Outcomes Research & Management, U.S. Medical & Scientific Affairs, Merck & Co., Inc., West Point, Pennsylvania
2 Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas

Although the individual components of the metabolic syndrome are clearly associated with increased risk for coronary heart disease (CHD), we wanted to quantify the increased prevalence of CHD among people with metabolic syndrome. The Third National Health and Nutrition Examination Survey (NHANES III) was used to categorize adults over 50 years of age by presence of metabolic syndrome (National Cholesterol Education Program [NCEP] definition) with or without diabetes. Demographic and risk factor information was determined for each group, as well as the proportion of each group meeting specific criteria for metabolic syndrome. The prevalence of CHD for each group was then determined. Metabolic syndrome is very common, with ~44% of the U.S. population over 50 years of age meeting the NCEP criteria. In contrast, diabetes without metabolic syndrome is uncommon (13% of those with diabetes). Older Americans over 50 years of age without metabolic syndrome regardless of diabetes status had the lowest CHD prevalence (8.7% without diabetes, 7.5% with diabetes). Compared with those with metabolic syndrome, people with diabetes without metabolic syndrome did not have an increase in CHD prevalence. Those with metabolic syndrome without diabetes had higher CHD prevalence (13.9%), and those with both metabolic syndrome and diabetes had the highest prevalence of CHD (19.2%) compared with those with neither. Metabolic syndrome was a significant univariate predictor of prevalent CHD (OR 2.07, 95% CI 1.66–2.59). However, blood pressure, HDL cholesterol, and diabetes, but not presence of metabolic syndrome, were significant multivariate predictors of prevalent CHD. The prevalence of CHD markedly increased with the presence of metabolic syndrome. Among people with diabetes, the prevalence of metabolic syndrome was very high, and those with diabetes and metabolic syndrome had the highest prevalence of CHD. Among all individuals with diabetes, prevalence of CHD was increased compared with those with metabolic syndrome without diabetes. However, individuals with diabetes without metabolic syndrome had no greater prevalence of CHD compared with those with neither.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
T. W.K. Ng, G. F. Watts, P. H. R. Barrett, K.-A. Rye, and D. C. Chan
Effect of Weight Loss on LDL and HDL Kinetics in the Metabolic Syndrome: Associations with changes in plasma retinol-binding protein-4 and adiponectin levels
Diabetes Care, November 1, 2007; 30(11): 2945 - 2950.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
C A Daly, P Hildebrandt, M Bertrand, R Ferrari, W Remme, M Simoons, K M Fox, and on behalf of the EUROPA investigators
Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial
Heart, November 1, 2007; 93(11): 1406 - 1411.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
I. Z. Ben-Dov, D. Ben-Ishay, J. Mekler, L. Ben-Arie, and M. Bursztyn
Increased Prevalence of Masked Blood Pressure Elevations in Treated Diabetic Subjects
Arch Intern Med, October 22, 2007; 167(19): 2139 - 2142.
[Full Text] [PDF]

Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
R. F. Zoeller JR
Physical Activity: The Role of Physical Activity and Fitness in the Prevention and Management of Type 2 Diabetes Mellitus
American Journal of Lifestyle Medicine, October 1, 2007; 1(5): 344 - 350.
[Abstract] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. R de Rooij, R. C Painter, F. Holleman, P. M. Bossuyt, and T. J Roseboom
The metabolic syndrome in adults prenatally exposed to the Dutch famine
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1219 - 1224.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. D. Brunzell
Hypertriglyceridemia
N. Engl. J. Med., September 6, 2007; 357(10): 1009 - 1017.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
F. Xue and K. B Michels
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 823S - 835S.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
N. Echahidi, P. Pibarot, J.-P. Despres, J.-M. Daigle, D. Mohty, P. Voisine, R. Baillot, and P. Mathieu
Metabolic Syndrome Increases Operative Mortality in Patients Undergoing Coronary Artery Bypass Grafting Surgery
J. Am. Coll. Cardiol., August 28, 2007; 50(9): 843 - 851.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. M Zivkovic, J B. German, and A. J Sanyal
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Am. J. Clinical Nutrition, August 1, 2007; 86(2): 285 - 300.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Lorenzo, M. Serrano-Rios, M. T. Martinez-Larrad, C. Gonzalez-Villalpando, J. L. Gonzalez-Sanchez, M. J. Martinez-Calatrava, R. Gabriel, and S. M. Haffner
Is Waist Circumference an Essential Component of the Metabolic Syndrome?
Diabetes Care, August 1, 2007; 30(8): 2141 - 2142.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
G. de Simone, R. B. Devereux, M. Chinali, L. G. Best, E. T. Lee, J. M. Galloway, H. E. Resnick, and for the Strong Heart Study Investigators
Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population With High Prevalence of Obesity and Diabetes: The Strong Heart Study
Diabetes Care, July 1, 2007; 30(7): 1851 - 1856.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Pravenec and T. W. Kurtz
Molecular Genetics of Experimental Hypertension and the Metabolic Syndrome: From Gene Pathways to New Therapies
Hypertension, May 1, 2007; 49(5): 941 - 952.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. Yang, N. Sambandam, X. Han, R. W. Gross, M. Courtois, A. Kovacs, M. Febbraio, B. N. Finck, and D. P. Kelly
CD36 Deficiency Rescues Lipotoxic Cardiomyopathy
Circ. Res., April 27, 2007; 100(8): 1208 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. Kahn
Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Circulation, April 3, 2007; 115(13): 1806 - 1811.
[Full Text] [PDF]

Home page
 CirculationHome page
R. S. Beaser and P. Levy
A Work in Progress, but a Useful Construct
Circulation, April 3, 2007; 115(13): 1812 - 1818.
[Full Text] [PDF]

Home page
 Circ. Res.Home page
E. Nisoli, E. Clementi, M. O. Carruba, and S. Moncada
Defective Mitochondrial Biogenesis: A Hallmark of the High Cardiovascular Risk in the Metabolic Syndrome?
Circ. Res., March 30, 2007; 100(6): 795 - 806.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
O. Toprak, M. Cirit, M. Yesil, S. Bayata, M. Tanrisev, U. Varol, R. Ersoy, and E. Esi
Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease
Nephrol. Dial. Transplant., March 1, 2007; 22(3): 819 - 826.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. M. Lloyd-Jones, K. Liu, L. A. Colangelo, L. L. Yan, L. Klein, C. M. Loria, C. E. Lewis, and P. Savage
Consistently Stable or Decreased Body Mass Index in Young Adulthood and Longitudinal Changes in Metabolic Syndrome Components: The Coronary Artery Risk Development in Young Adults Study
Circulation, February 27, 2007; 115(8): 1004 - 1011.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. S. Sun, G. D. Grave, R. M. Siervogel, A. A. Pickoff, S. S. Arslanian, and S. R. Daniels
Systolic Blood Pressure in Childhood Predicts Hypertension and Metabolic Syndrome Later in Life
Pediatrics, February 1, 2007; 119(2): 237 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
G. Razay, A. Vreugdenhil, and G. Wilcock
The Metabolic Syndrome and Alzheimer Disease
Arch Neurol, January 1, 2007; 64(1): 93 - 96.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. Mancia, M. Bombelli, G. Corrao, R. Facchetti, F. Madotto, C. Giannattasio, F. Q. Trevano, G. Grassi, A. Zanchetti, and R. Sega
Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis
Hypertension, January 1, 2007; 49(1): 40 - 47.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. D Griffin, T. A. Sanders, I. G Davies, L. M Morgan, D J. Millward, F. Lewis, S. Slaughter, J. A Cooper, G. J Miller, and B. A Griffin
Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1290 - 1298.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
A. MITRAKOU
Women's Health and the Metabolic Syndrome
Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 33 - 48.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
the Metascreen Writing Committee
The Metabolic Syndrome Is a Risk Indicator of Microvascular and Macrovascular Complications in Diabetes: Results from Metascreen, a multicenter diabetes clinic-based survey
Diabetes Care, December 1, 2006; 29(12): 2701 - 2707.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Subramanian, M. A. DeRosa, C. Bernal-Mizrachi, N. Laffely, W. T. Cade, K. E. Yarasheski, P. E. Cryer, and C. F. Semenkovich
PPAR{alpha} activation elevates blood pressure and does not correct glucocorticoid-induced insulin resistance in humans
Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1365 - E1371.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. Iribarren, A. S. Go, G. Husson, S. Sidney, J. M. Fair, T. Quertermous, M. A. Hlatky, and S. P. Fortmann
Metabolic Syndrome and Early-Onset Coronary Artery Disease: Is the Whole Greater Than Its Parts?
J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1800 - 1807.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Oda
Criteria for diagnosing the metabolic syndrome.
Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1251 - 1252.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Oda
The metabolic syndrome (emperor) wears no clothes: response to kahn.
Diabetes Care, November 1, 2006; 29(11): 2566 - 2566.
[Full Text] [PDF]

Home page
 CJASNHome page
K. Armstrong, D. Rakhit, L. Jeffriess, D. Johnson, R. Leano, J. Prins, L. Garske, T. Marwick, and N. Isbel
Cardiorespiratory Fitness Is Related to Physical Inactivity, Metabolic Risk Factors, and Atherosclerotic Burden in Glucose-Intolerant Renal Transplant Recipients
Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1275 - 1283.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Wu, R. Vikramadithyan, S. Yu, C. Pau, Y. Hu, I. J. Goldberg, and H. M. Dansky
Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis
J. Lipid Res., October 1, 2006; 47(10): 2215 - 2222.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. S.C. Korf, L. R. White, P. Scheltens, and L. J. Launer
Brain Aging in Very Old Men With Type 2 Diabetes: The Honolulu-Asia Aging Study
Diabetes Care, October 1, 2006; 29(10): 2268 - 2274.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
B. H. Sanders, L. M Lubsch, and D. S West
Prevalence and Treatment of Metabolic Syndrome in Adolescents with Type 2 Diabetes
Ann. Pharmacother., September 1, 2006; 40(9): 1517 - 1521.
[Abstract] [Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
K. E. Thorpe and D. H. Howard
The Rise In Spending Among Medicare Beneficiaries: The Role Of Chronic Disease Prevalence And Changes In Treatment Intensity
Health Aff., September 1, 2006; 25(5): w378 - w388.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. E. Kahn, B. Zinman, S. M. Haffner, M. C. O'Neill, B. G. Kravitz, D. Yu, M. I. Freed, W. H. Herman, R. R. Holman, N. P. Jones, et al.
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes.
Diabetes, August 1, 2006; 55(8): 2357 - 2364.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
M. Blaha and T. A. Elasy
Clinical Use of the Metabolic Syndrome: Why the Confusion?
Clin. Diabetes, July 1, 2006; 24(3): 125 - 131.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. M. Grundy
Does the Metabolic Syndrome Exist?
Diabetes Care, July 1, 2006; 29(7): 1689 - 1692.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Kahn
The Metabolic Syndrome (Emperor) Wears No Clothes
Diabetes Care, July 1, 2006; 29(7): 1693 - 1696.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. M Grundy
Does a diagnosis of metabolic syndrome have value in clinical practice?
Am. J. Clinical Nutrition, June 1, 2006; 83(6): 1248 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
Y. A Carpentier, L. Portois, and W. J Malaisse
n-3 Fatty acids and the metabolic syndrome
Am. J. Clinical Nutrition, June 1, 2006; 83(6): S1499 - 1504S.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
R. Katz, N. D. Wong, R. Kronmal, J. Takasu, D. M. Shavelle, J. L. Probstfield, A. G. Bertoni, M. J. Budoff, and K. D. O'Brien
Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis
Circulation, May 2, 2006; 113(17): 2113 - 2119.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. Maggi, M. Noale, P. Gallina, D. Bianchi, C. Marzari, F. Limongi, G. Crepaldi, and for the ILSA Working Group
Metabolic syndrome, diabetes, and cardiovascular disease in an elderly caucasian cohort: the italian longitudinal study on aging.
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2006; 61(5): 505 - 510.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Butler, N. Rodondi, Y. Zhu, K. Figaro, S. Fazio, D. E. Vaughan, S. Satterfield, A. B. Newman, B. Goodpaster, D. C. Bauer, et al.
Metabolic Syndrome and the Risk of Cardiovascular Disease in Older Adults
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1595 - 1602.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Natali, E. Toschi, S. Baldeweg, D. Ciociaro, S. Favilla, L. Sacca, and E. Ferrannini
Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.
Diabetes, April 1, 2006; 55(4): 1133 - 1140.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S. M. Grundy
Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1093 - 1100.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. H. Wild, C. D. Byrne, F. B. Smith, A. J. Lee, and F. G. R. Fowkes
Low ankle-brachial pressure index predicts increased risk of cardiovascular disease independent of the metabolic syndrome and conventional cardiovascular risk factors in the edinburgh artery study.
Diabetes Care, March 1, 2006; 29(3): 637 - 642.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F. F. Samaha, P. O. Szapary, N. Iqbal, M. M. Williams, L. T. Bloedon, A. Kochar, M. L. Wolfe, and D. J. Rader
Effects of Rosiglitazone on Lipids, Adipokines, and Inflammatory Markers in Nondiabetic Patients With Low High-Density Lipoprotein Cholesterol and Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 624 - 630.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
P. Kohli and P. Greenland
Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease
JAMA, February 15, 2006; 295(7): 819 - 821.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
K. H. Liu, Y. L. Chan, W. B. Chan, J. C. N. Chan, and C. W. W. Chu
Mesenteric Fat Thickness Is an Independent Determinant of Metabolic Syndrome and Identifies Subjects With Increased Carotid Intima-Media Thickness
Diabetes Care, February 1, 2006; 29(2): 379 - 384.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. M. Grundy
Diabetes and Coronary Risk Equivalency: What does it mean?
Diabetes Care, February 1, 2006; 29(2): 457 - 460.
[Full Text] [PDF]

Home page
 HeartHome page
A Cordero and E Alegria
Sex differences and cardiovascular risk
Heart, February 1, 2006; 92(2): 145 - 146.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. E. Eberly, R. Prineas, J. D. Cohen, G. Vazquez, X. Zhi, J. D. Neaton, L. H. Kuller, and for the Multiple Risk Factor Intervention Trial Re
Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial
Diabetes Care, January 1, 2006; 29(1): 123 - 130.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Fortuno, G. San Jose, M. U. Moreno, O. Beloqui, J. Diez, and G. Zalba
Phagocytic NADPH Oxidase Overactivity Underlies Oxidative Stress in Metabolic Syndrome
Diabetes, January 1, 2006; 55(1): 209 - 215.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
A. Sato, L. Tarnow, F.S. Nielsen, E. Knudsen, and H.-H. Parving
Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment
QJM, December 1, 2005; 98(12): 879 - 884.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. M. Grundy, J. I. Cleeman, S. R. Daniels, K. A. Donato, R. H. Eckel, B. A. Franklin, D. J. Gordon, R. M. Krauss, P. J. Savage, S. C. Smith Jr, et al.
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
Circulation, October 25, 2005; 112(17): 2735 - 2752.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
2nd International Symposium on Triglycerides and HDL: Metabolic syndrome
Diabetes Care, October 1, 2005; 28(10): 2577 - 2584.
[Full Text] [PDF]

Home page
 DiabetesHome page
S. Bacci, O. Ludovico, S. Prudente, Y.-Y. Zhang, R. Di Paola, D. Mangiacotti, A. Rauseo, D. Nolan, J. Duffy, G. Fini, et al.
The K121Q Polymorphism of the ENPP1/PC-1 Gene Is Associated With Insulin Resistance/Atherogenic Phenotypes, Including Earlier Onset of Type 2 Diabetes and Myocardial Infarction
Diabetes, October 1, 2005; 54(10): 3021 - 3025.
[Abstract] [Full Text] [PDF]